lobbying_activities: 2818690

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2818690	ecf1699f-cac4-4313-a7ec-e7dfbec1902f	Q2	SAM ACTION, INC.	401104337	SAM ACTION, INC.	2022	second_quarter	MED	H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE		10000	0	0	2022-07-14T09:38:25-04:00